Evidence map›Paper›PMID 28149906›Full record

ArticleAnnals of translational medicine2016

Targeting NF2-Hippo/Yap signaling pathway for cardioprotection after ischemia/reperfusion injury.

Masum M Mia, Ayshwarya L Chelakkot-Govindalayathil, Manvendra K Singh

Abstract readComment
In one paragraph

Article in Annals of translational medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. The Hippo Signaling Pathway in Cardiac Development and Diseases.Frontiers in cell and developmental biology · 2019
    Review
  9. Article
  10. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Masum M MiaProgram in Cardiovascular and Metabolic Disorders, Duke-NUS Medical School Singapore, Singapore 169857, Singapore.
Ayshwarya L Chelakkot-GovindalayathilProgram in Cardiovascular and Metabolic Disorders, Duke-NUS Medical School Singapore, Singapore 169857, Singapore.
Manvendra K SinghProgram in Cardiovascular and Metabolic Disorders, Duke-NUS Medical School Singapore, Singapore 169857, Singapore; ; National Heart Research Institute Singapore, National Heart Center Singapore, Singapore 169609, Singapore.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID28149906
PMCPMC5233495

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.